Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
NEW YORK, Aug. 13, 2013 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS) (“NeoStem” or the “Company”), a leader in the emerging cellular therapy market, announced today that the Company and its subsidiary, Progenitor Cell Therapy (“PCT”), will present at two conferences in August.
Help employers find you! Check out all the jobs and post your resume.
